Monitoring asthma: state-of-the-art physiological, imaging, and biomarker assessments Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2016
Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments Source: International Congress 2015 – PG2 Asthma and COPD Year: 2015
Monitoring asthma - state-of-the-art physiological, imaging and biomarker assessments Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2018
Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017
Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020 Year: 2021
Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG]) Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016
Influence of condensing equipment parameters on EBC biomarkers Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function? Year: 2009
Development of new method for off-line measurement of exhaled NO (FENO) compatible to on-line method Source: Eur Respir J 2004; 24: Suppl. 48, 267s Year: 2004
Back to the future: integrating breath analysis in lung function equipment Source: International Congress 2015 – The next generation of lung function tests Year: 2015
Free running asthma screening test (FRAST): a useful tool or a waste of time? Source: Eur Respir J 2001; 18: Suppl. 33, 495s Year: 2001
Recommendations and pitfalls in measurements of EBC compounds Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate Year: 2007
Detection of angiogenesis, antiangiogenesis and hypoxia related molecules in plasma and exhaled breath condensate (EBC): evaluation of potential biomarkers Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009
Standardization of collection of exhaled breath condensate (EBC) for disease markers in use of different condensers Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003
On the temporal characterisation of novel capnometric indices for personalised monitoring and treatment optimisation of COPD Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019
Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Source: International Congress 2015 – The next generation of lung function tests Year: 2015
The validation of assays used to measure biomarkers in exhaled breath condensate Source: Eur Respir J 2008; 32: 1408-1409 Year: 2008